Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin(®)) in patients with advanced non-squamous non-small cell lung canc...

por Li, Cheryl S. W., Sweeney, Kevin, Cronenberger, Carol
Publicado 2019

Atomic-like spin noise in solid-state demonstrated with manganese in cadmium telluride

por Cronenberger, S., Scalbert, D., Ferrand, D., Boukari, H., Cibert, J.
Publicado 2015

Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States?

por Alvarez, Daniel F., Wolbink, Gertjan, Cronenberger, Carol, Orazem, John, Kay, Jonathan
Publicado 2020

Randomized, Open‐Label, Single‐Dose, Parallel‐Group Pharmacokinetic Study of PF‐06410293 (adalimumab‐afzb), an Adalimumab Biosimilar, by Subcutaneous Dosing Using a Prefilled Syrin...

por Cox, Donna S., Alvarez, Daniel F., Bock, Amy E., Cronenberger, Carol L.
Publicado 2021

Mortality of hospital or community-acquired Legionnaires’ disease (LD): a prospective study

por Cronenberger, SP, Chidiac, C, Campese, C, Che, D, Jarraud, S, Benet, T, Vanheims, P
Publicado 2011

Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis

por Cohen, Stanley B., Burgos‐Vargas, Rubén, Emery, Paul, Jin, Bo, Cronenberger, Carol, Vázquez‐Abad, María‐Dolores
Publicado 2018

Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a...

por Fleischmann, Roy M, Alvarez, Daniel F, Bock, Amy E, Cronenberger, Carol, Vranic, Ivana, Zhang, Wuyan, Alten, Rieke
Publicado 2021

Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®)...

por Fleischmann, Roy M., Alvarez, Daniel F., Bock, Amy E., Cronenberger, Carol, Vranic, Ivana, Zhang, Wuyan, Alten, Rieke
Publicado 2021

Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis

por Fleischmann, Roy M., Bock, Amy E., Zhang, Wuyan, Godfrey, Charles M., Vranic, Ivana, Cronenberger, Carol, Dokoupilová, Eva
Publicado 2022

Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients

por Bénet, Thomas, Régis, Corinne, Voirin, Nicolas, Robert, Olivier, Lina, Bruno, Cronenberger, Silene, Comte, Brigitte, Coppéré, Brigitte, Vanhems, Philippe
Publicado 2012

Construction of a polarized beam with both spin orientations at the CERN synchrocyclotron

por Coignet, G, Cronenberger, D, Kuroda, K, Le Guen, Y, Michalowicz, A, Olivier, J C, Dick, Louis, Di Lella, L
Publicado 1966

Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance

por Byon, W, Smith, MK, Chan, P, Tortorici, MA, Riley, S, Dai, H, Dong, J, Ruiz‐Garcia, A, Sweeney, K, Cronenberger, C
Publicado 2013

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis

por Fleischmann, Roy M., Alten, Rieke, Pileckyte, Margarita, Lobello, Kasia, Hua, Steven Y., Cronenberger, Carol, Alvarez, Daniel, Bock, Amy E., Sewell, K. Lea
Publicado 2018

Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study

por Landen, Jaren W., Andreasen, Niels, Cronenberger, Carol L., Schwartz, Pamela F., Börjesson-Hanson, Anne, Östlund, Henrik, Sattler, Catherine A., Binneman, Brendon, Bednar, Martin M.
Publicado 2017

Proposal: Measurement of the recoil proton polarization parameter in the backward $\pi^{\pm} p$ elastic scattering at high energies

por Borghini, M, Dick, Louis, Olivier, J C, Navarro, A, Caverzasio, C, Cronenberger, D, Grégoire, G, Janout, Z, Kuroda, K, Michalowicz, A, Poulet, M, Sillou, D
Publicado 1969

Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or C...

por Cohen, Stanley B., Radominski, Sebastiao C., Kameda, Hideto, Kivitz, Alan J., Tee, Michael, Cronenberger, Carol, Zhang, Min, Hackley, Sarah, Rehman, Muhammad I., von Richter, Oliver, Alten, Rieke
Publicado 2020

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to we...

por Alten, Rieke, Batko, Bogdan, Hala, Tomas, Kameda, Hideto, Radominski, Sebastiao C, Tseluyko, Vira, Babic, Goran, Cronenberger, Carol, Hackley, Sarah, Rehman, Muhammad, von Richter, Oliver, Zhang, Min, Cohen, Stanley
Publicado 2019

Proposal for measurements of the polarization parameter $P_{0}$ in $\pi^{\pm}p, pp, \bar{p}p,$ and $ K^{\pm}p$ elastic scattering using a polarized target

por Borghini, M, Dick, Louis, Lella di, L, Macq, Pierre C, Olivier, J C, Coignet, G, Cronenberger, D, Kuroda, K, Michalowicz, A, Poulet, M, Bellettini, G, Bemporad, C, Braccini, Pier Luigi, Foà, L
Publicado 1966

Memorandum: Experimental programme to study spin effects in high energy elastic scattering reactions

por Bellettini, G, Bemporad, C, Beurtey, R, Borghini, M, Braccini, Pier Luigi, Coignet, G, Cronenberger, D, Dick, Louis, Foà, L, Kuroda, K, Di Lella, L, Macq, Pierre C, Michalowicz, A, Olivier, J C, Poulet, M
Publicado 1966

Measurement of the polarization parameter in hadron scattering at high energies

por Borghini, M, Dick, Louis, Navarro, A, Olivier, J, Cronenberger, D, Grégoire, G, Kuroda, K, Michalowicz, A, Poulet, M, Sillou, D, Bellettini, G, Braccini, Pier Luigi, Del Prete, T, Foà, L, Laurelli, P, Sanguinetti, G, Valdata, M
Publicado 1970